CYP24A1 and neoplasm: A number of aminobenzenesulfonamides demonstrated high (in some cases even picomolar) inhibitory activity against various isoenzymes of hCA, such as physiologically important hCA I, hCA II, or tumor-associated hCA IX and hCA XII [29,30,31].